Wednesday, November 21, 2012- The P/E Ratio, Health Care, and Youat Motley Fool (Wed, Nov 21)
- CHMP Positive on Novartis DrugsZacks (Wed, Nov 21)
- Stillman & Friedman, DLA Piper, Hogan: Business of Lawat Bloomberg (Wed, Nov 21)
- Pfizer Destroyed Arthritis Drugs’ Files, Investors Claimat Bloomberg (Wed, Nov 21)
- Eliquis (Apixaban) Approved In Europe - A Blockbuster Opportunity For Bristol-Myers, Pfizerat Seeking Alpha (Wed, Nov 21)
- BMY/PFE's Eliquis Cleared in the EUZacks (Wed, Nov 21)
- Pfizer's Xeljanz Gets Approval, While Lilly's Baricitinib Looks Strongat Seeking Alpha (Wed, Nov 21)
- An Interesting Emerging Market ADRat Motley Fool (Wed, Nov 21)
- Forbes Health Summit To Feature FDA Commissioner Margaret Hamburg And Texas Governor Rick Perryat Forbes (Wed, Nov 21)
- Martoma Fund Used Dark Pool to Keep Insider Trading Quietat Bloomberg (Wed, Nov 21)
- 1 Risk You Must Understand With This Spinoffat Motley Fool (Wed, Nov 21)
- Pfizer's Lyrica Scores in StudyZacks (Wed, Nov 21)
- Vivus Stock Soars As Aetna Adds Qsymia To Coverageat Investor's Business Daily (Wed, Nov 21)
- Bristol-Pfizer Anticlotting Drug Gets Key EU Approvalat Motley Fool (Wed, Nov 21)
- Revisiting Buyout Rumors After Teva's CEO Shifts Focus To 'Smaller Acquisitions'at Seeking Alpha (Wed, Nov 21)
- Shire, Boston Children's, sign research agreementat bizjournals.com (Wed, Nov 21)
- Insider Crackdown Uses SAC Manager in Health-Care Pivotat Bloomberg (Wed, Nov 21)
- Insider Crackdown Uses SAC Manager to Pivot to Fraudat Bloomberg (Wed, Nov 21)
- Ex-SAC Manager Was ‘Pupil’ of Doctor Accused of Tipsat Bloomberg (Wed, Nov 21)
Tuesday, November 20, 2012Add PFE News to My Yahoo!   | |
|
0.35 (1.19%) 6:25AM EDT - Nasdaq Real Time Price